Use Case: Telehealth
Drug Interaction Safety for Telehealth Prescribing
Telehealth providers prescribe remotely without a pharmacist at the point of care. Add real-time drug interaction checking to your virtual visit workflow with a single API call.
Telehealth providers prescribe remotely without a pharmacist at the point of care. Add real-time drug interaction checking to your virtual visit workflow with a single API call.
Telehealth visits have fundamentally changed how patients receive prescriptions. A provider conducting a virtual visit can prescribe medications, including controlled substances under current DEA flexibilities, without the patient ever visiting a physical clinic or pharmacy. This convenience creates a critical safety gap: there is no pharmacist or clinical pharmacologist physically present at the point of prescribing to catch dangerous drug combinations.
In a traditional in-person workflow, prescriptions pass through multiple safety checkpoints. The prescriber enters the order in the EHR, which may have its own interaction checking. The prescription is then transmitted to a pharmacy, where a pharmacist reviews it against the patient's medication profile. In telehealth, especially for platforms that dispense directly or use mail-order pharmacies, these intermediate safety checks may be reduced or delayed.
The growth of telehealth has been dramatic. The American Medical Association reports that telehealth visits accounted for a significant portion of outpatient encounters following the pandemic-era expansion, and many of these visits result in new prescriptions. When a provider prescribes during a 15-minute video call, they may be working from a patient's self-reported medication list that is incomplete or inaccurate. Without automated interaction checking at the point of prescribing, dangerous combinations can slip through.
This is where a drug interaction API becomes essential for telehealth platforms. By integrating interaction checking directly into the prescribing workflow of the telehealth application, platforms can ensure that every prescription is screened against the patient's known medications before it is transmitted to a pharmacy.
Telehealth prescribing is governed by a complex patchwork of federal and state regulations. While the specific requirements vary by jurisdiction, several consistent themes affect how telehealth platforms should approach drug interaction safety.
Most state medical boards require telehealth providers to meet the same standard of care as in-person visits. This includes performing appropriate clinical assessments before prescribing, which extends to verifying that a new prescription does not interact dangerously with the patient's existing medications. An automated drug interaction check at the point of prescribing helps telehealth platforms demonstrate compliance with this standard.
For controlled substances, the Ryan Haight Online Pharmacy Consumer Protection Act establishes requirements for telehealth prescribing. While the DEA has extended pandemic-era flexibilities, telehealth platforms prescribing controlled substances face heightened scrutiny. Drug interaction checking adds a documented safety layer that demonstrates the platform is applying clinical safeguards beyond the minimum regulatory requirements.
Several state pharmacy boards have adopted or proposed rules requiring electronic prescribing systems to include drug interaction checking capabilities. For telehealth platforms that transmit prescriptions electronically, meeting these requirements means integrating an interaction checking system that screens prescriptions before transmission to the pharmacy.
The RxLabelGuard API receives drug names, not patient identifiers. The API does not process, store, or transmit any protected health information (PHI). Drug names are checked against FDA label data and interaction results are returned. Your telehealth platform retains full control over patient data, and no HIPAA Business Associate Agreement is required for the interaction checking API itself.
Integrating drug interaction checking into a telehealth platform follows a straightforward pattern. The check happens server-side when the provider initiates a prescription during or after the virtual visit. The telehealth app's backend collects the patient's medication list, calls the RxLabelGuard API, and presents any interactions to the provider before the prescription is finalized.
The RxLabelGuard API is called from your telehealth platform's backend, not from the provider's browser or mobile app. Your backend collects the patient's medication list (either from the patient intake form, the platform's patient record, or an integrated EHR), adds the newly prescribed medication, and sends the full list to the API. Results are returned to the frontend for the provider to review.
This server-to-server pattern keeps your API key secure, allows you to enrich the request with data from your patient database, and ensures consistent error handling regardless of the provider's device or connection quality.
Integrate drug interaction checking into your telehealth platform with a single REST call. Here are production-ready examples for common telehealth backend stacks.
Test from the command line. Replace YOUR_API_KEY with the key from your dashboard.
curl -X POST https://jd6095ijga.execute-api.us-east-2.amazonaws.com/v1/interactions/check \
-H "Content-Type: application/json" \
-H "x-api-key: YOUR_API_KEY" \
-d '{
"drugs": ["sertraline", "tramadol", "lisinopril"],
"format": "structured"
}'A prescribing middleware that checks interactions before allowing a prescription to be transmitted.
interface InteractionPair {
drug1: string;
drug2: string;
severity: "contraindicated" | "major" | "moderate" | "minor" | "unknown";
mechanism: string;
recommendation: string;
evidence: { splSetId: string; section: string; snippet: string };
}
const API_URL =
"https://jd6095ijga.execute-api.us-east-2.amazonaws.com/v1/interactions/check";
async function checkBeforePrescribing(
currentMedications: string[],
newPrescription: string,
apiKey: string
): Promise<{ safe: boolean; alerts: InteractionPair[] }> {
const allDrugs = [...currentMedications, newPrescription];
const response = await fetch(API_URL, {
method: "POST",
headers: {
"Content-Type": "application/json",
"x-api-key": apiKey,
},
body: JSON.stringify({ drugs: allDrugs, format: "structured" }),
});
if (!response.ok) {
throw new Error(`RxLabelGuard API error: ${response.status}`);
}
const result = await response.json();
const critical = result.pairs.filter(
(p: InteractionPair) =>
p.severity === "contraindicated" || p.severity === "major"
);
return {
safe: critical.length === 0,
alerts: result.pairs,
};
}
// Example: Provider prescribes tramadol for a patient on sertraline
const result = await checkBeforePrescribing(
["sertraline", "lisinopril"], // patient's current meds
"tramadol", // new prescription
process.env.RXLABELGUARD_API_KEY!
);
if (!result.safe) {
// Block prescription, show interaction alert to provider
console.log("Critical interactions detected:", result.alerts);
}Interaction checking integrated into a telehealth prescribing endpoint.
import requests
import os
RXLABELGUARD_URL = (
"https://jd6095ijga.execute-api.us-east-2.amazonaws.com"
"/v1/interactions/check"
)
def check_telehealth_prescription(
current_meds: list[str],
new_drug: str,
api_key: str
) -> dict:
"""Check interactions before transmitting a telehealth prescription."""
all_drugs = current_meds + [new_drug]
response = requests.post(
RXLABELGUARD_URL,
headers={
"x-api-key": api_key,
"Content-Type": "application/json",
},
json={"drugs": all_drugs, "format": "structured"},
timeout=10,
)
response.raise_for_status()
result = response.json()
# Separate critical alerts from informational
critical = [
p for p in result.get("pairs", [])
if p["severity"] in ("contraindicated", "major")
]
return {
"has_critical": len(critical) > 0,
"critical_alerts": critical,
"all_interactions": result.get("pairs", []),
"request_id": result.get("requestId"),
}
# Example: Virtual visit prescription check
result = check_telehealth_prescription(
current_meds=["sertraline", "lisinopril"],
new_drug="tramadol",
api_key=os.environ["RXLABELGUARD_API_KEY"],
)
if result["has_critical"]:
print("ALERT: Critical interactions found")
for alert in result["critical_alerts"]:
print(f" {alert['drug1']} + {alert['drug2']}: {alert['severity']}")
print(f" {alert['mechanism']}")For complete API documentation, including error handling, rate limit headers, and the natural-language /ask endpoint, see the full API documentation.
Drug interaction checking is relevant across multiple telehealth specialties and workflows. Here are common scenarios where the RxLabelGuard API provides critical safety coverage.
Psychiatric telehealth is one of the fastest-growing specialties. Providers frequently prescribe SSRIs, SNRIs, benzodiazepines, and mood stabilizers. These drug classes have numerous clinically significant interactions. A psychiatrist conducting a virtual follow-up who adds a new antidepressant needs immediate feedback on interactions with the patient's existing psychiatric medications and any other drugs the patient reports taking.
Patient on sertraline reports starting St. John's Wort from a health food store. The API flags a major interaction (serotonin syndrome risk) during the virtual visit.
Primary care telehealth handles the broadest range of prescribing. A family medicine provider may prescribe antibiotics, antihypertensives, diabetes medications, and pain management drugs in a single shift. The diversity of prescribing makes automated interaction checking essential because no provider can memorize every possible interaction across all drug classes.
Provider prescribes ciprofloxacin for a UTI. API detects interaction with the patient's existing tizanidine (major: increased tizanidine levels and risk of hypotension).
On-demand telehealth platforms connect patients with available providers who have no prior relationship with the patient. The provider relies entirely on the patient's self-reported medication list, which may be incomplete. Interaction checking is especially critical because the provider lacks the longitudinal relationship and chart history that a regular physician would have.
Patient requests treatment for insomnia. Reports taking 'a blood thinner.' Provider identifies warfarin. API checks the proposed sleep medication against warfarin and all reported medications.
Telehealth platforms for chronic disease management (diabetes, hypertension, heart failure) involve patients on complex multi-drug regimens. Medication adjustments during virtual check-ins must be screened against all existing medications. These patients are often on 5-10 medications, creating dozens of potential interaction pairs that need automated screening.
Cardiologist adjusts a heart failure patient's ACE inhibitor dosage and adds spironolactone. API flags the potassium-related interaction risk that requires monitoring.
Platforms prescribing controlled substances under DEA telehealth authorities face heightened regulatory scrutiny. Drug interaction checking provides a documented safety layer. When a provider prescribes a controlled substance, the interaction check result (including any override decisions) becomes part of the audit trail that demonstrates responsible prescribing practices.
Provider prescribes alprazolam for anxiety. API detects the patient is already on opioid pain medication and flags the contraindicated benzodiazepine-opioid combination with FDA boxed warning citation.
During a virtual visit, any delay in the prescribing workflow is felt immediately by both the provider and the patient. A drug interaction check that takes several seconds disrupts the flow of the consultation and encourages providers to skip the safety step. RxLabelGuard is designed for the latency requirements of real-time telehealth.
Previously resolved drug pairs return from DynamoDB cache in under 200ms, imperceptible during a virtual visit.
First-time lookups complete in under 2 seconds. Results are then cached for subsequent checks.
Send the patient's full medication list. The API checks all pairwise combinations in a single call.
Professional tier includes a 99.5% uptime SLA. AWS Lambda infrastructure scales automatically.
Start free during development. Scale to production without enterprise sales cycles or long-term contracts.
Development and testing
Pilot telehealth deployments
Production telehealth workloads
All tiers include structured JSON responses, severity scoring, and FDA evidence citations. No hidden fees.
View full pricing details and feature comparisonYes. Most states require telehealth prescribers to follow the same standard of care as in-person visits, which includes checking for drug-drug interactions before prescribing. Without a pharmacist physically present, automated interaction checking at point-of-prescribing is the primary safety net.
Cached drug pairs return in under 200ms. First-time lookups (involving drug resolution and label retrieval) complete in under 2 seconds. Both are fast enough for real-time use during a virtual visit without disrupting the clinical workflow.
Yes. The API checks interactions for any drug with an FDA label, including controlled substances. This is particularly important for telehealth platforms prescribing controlled substances under DEA telehealth flexibilities, where interaction checking adds an additional safety layer.
RxLabelGuard provides drug interaction data, not prescribing authorization. The Ryan Haight Act governs controlled substance prescribing requirements (like in-person evaluations). RxLabelGuard complements compliance by ensuring prescribed medications are checked for interactions, but platforms must separately ensure Ryan Haight compliance for controlled substance prescribing.
Any telehealth platform with a backend server can integrate. The API is a standard REST endpoint that accepts drug names and returns structured interaction data. It works with custom-built telehealth apps, white-label platforms, and telehealth features embedded in EHR systems.
Adding drug interaction checking to your telehealth platform typically takes a few hours of development time. Follow these steps to go from first API call to production.
Sign up at rxlabelguard.com/register. No credit card required. Generate an API key from your dashboard for the x-api-key header.
Use the code examples above to test with drug combinations common in your specialty. Start with well-known interactions like sertraline + tramadol (serotonin syndrome risk) to verify your setup. See the API documentation for complete request/response schemas.
Add the interaction check to your prescribing flow. The check should happen after the provider selects a medication but before the prescription is finalized and transmitted. Handle API errors gracefully with a fallback that allows prescribing to continue with a logged warning.
Map severity levels to alert types. Contraindicated and major interactions should interrupt the prescribing flow with a modal. Moderate interactions can appear as a non-blocking notification. See our alert fatigue guide for UX best practices.
Upgrade to Developer ($20/mo) or Professional ($99/mo) from your dashboard when you are ready for production traffic. Monitor usage analytics and scale your tier as visit volume grows.
Guides and documentation for drug interaction API integration.
Detailed guide to integrating drug interaction checking into EHR systems and CPOE workflows.
Step-by-step tutorial for building drug interaction checks into your application.
How five-level severity classification reduces alert override rates.
Comprehensive overview of drug interaction APIs and how to choose one.
Details on the free Sandbox tier with full structured output.
Side-by-side comparison of RxLabelGuard, openFDA, DrugBank, and enterprise vendors.
Create a free account, generate an API key, and start checking drug interactions in under five minutes. No sales calls, no credit card required.
Already have an account? Go to your dashboard
Medical Disclaimer
This information is derived from FDA Structured Product Labeling and is provided for informational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making clinical decisions. RxLabelGuard provides drug interaction data for integration into clinical decision support systems and is not a substitute for clinical judgment.